Filter
1332
Filtered Results: 1332
Text search:
M.Johnson
Featured
Recommendations
113
New Publications
263
Language
Document type
No document type
700
Studies & Reports
292
Guidelines
206
Manuals
72
Strategic & Response Plan
20
Training Material
17
Fact sheets
17
Situation Updates
5
Infographics
2
Brochures
1
Countries / Regions
Global
51
India
41
Kenya
28
Liberia
27
Sierra Leone
23
South Africa
23
Western and Central Europe
22
Latin America and the Carribbean
20
Russia
20
Africa
17
Congo, Democratic Republic of
16
Brazil
16
Malawi
14
Uganda
14
Ukraine
12
Nigeria
12
Germany
12
Lesotho
11
Tanzania
11
Eastern Europe
11
Indonesia
11
Nepal
10
Bangladesh
10
Ethiopia
10
Rwanda
9
Zimbabwe
9
Mozambique
9
Zambia
9
Senegal
8
Burkina Faso
8
Paraguay
8
Cameroon
7
Philippines
7
Guinea
7
Bolivia
7
Ghana
6
Haiti
6
Middle East and North Africa
6
South–East Asia Region
6
Argentina
6
Myanmar / Burma
6
Colombia
5
Thailand
4
Benin
4
Chile
4
Syria
4
USA
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Angola
4
Ecuador
4
Eswatini/ Swaziland
4
China
3
Estonia
3
Asia
3
East and Southern Africa
3
Botswana
3
South Sudan
3
North Macedonia
2
Tajikistan
2
Peru
2
Malaysia
2
Cambodia
2
Guinea-Bissau
2
Venezuela
2
Western Pacific Region
2
Jamaica
2
Spain
2
Namibia
2
Mali
2
El Salvador
1
Canada
1
Singapore
1
Kyrgyzstan
1
Niger
1
Burundi
1
Armenia
1
Japan
1
Belgium
1
United Kingdom
1
Portugal
1
Belarus
1
Southern Africa
1
Vietnam
1
Papua New Guinea
1
Egypt
1
Yemen
1
Palestine
1
Georgia
1
Central African Republic
1
Chad
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
378
Clinical Guidelines
134
Women & Child Health
82
Public Health
70
Key Resources
32
Capacity Building
27
Pharmacy & Technologies
14
Toolboxes
Mental Health
180
HIV
129
COVID-19
114
TB
75
Planetary Health
66
Caregiver
57
Ebola
45
AMR
41
NTDs
38
Disability
36
NCDs
31
Global Health Education
25
Pharmacy
23
Rapid Response
22
Zika
18
Health Financing Toolbox
14
Refugee
12
Natural Hazards
11
Social Ethics
9
Conflict
9
Cholera
3
Polio
2
Specific Hazards
1
Editorial Review
AIDS 2019, 33:1411–1420
Anema et al. AIDS Research and Therapy 2011, 8:13 http://www.aidsrestherapy.com/content/8/1/13
Previous studies have highlighted a range of individual determinants associated with HIV testing but few have assessed the role of contextual factors. The objective of this paper is to examine the influence of both individual and community-level determinants of HIV testing uptake in Burkina Faso.
Sustainability Science (2019) 14:1343–1354
Nat Med (2021). https://doi.org/10.1038/s41591-021-01381-y
Low- and middle-income countries (LMICs) experience a high disease burden for epilepsy, a chronic neurological condition.The authors evaluate the cost-effectiveness of community health workers (CHWs) to improve adherence to medication for epilepsy in South Africa. They found that utilizing CHWs to i...
Policy Brief. More languages available here https://apps.who.int/iris/handle/10665/179517
In one of his final essays, statesman and former United Nations secretary general Kofi Annan said, ‘Snakebite is the most important tropical disease you’ve never heard of’. Mr. Annan firmly believed that victims of snakebite envenoming should be recognised and afforded greater efforts at impro...
Background: In 2015, 5.3 million babies died in the third trimester of pregnancy and first month following birth. Progress in reducing neonatal mortality and stillbirth rates has lagged behind the substantial progress in reducing postneonatal and maternal mortality rates. The benefits to prenatal an...
Background:Neonatal mortality accounts for 43% of global under-five deaths and is decreasing more slowly than maternal or child mortality. Donor funding has increased for maternal, newborn, and child health (MNCH), but no analysis to date has disaggregated aid for newborns. We evaluated if and how a...
The evolving epidemic of type 2 diabetes mellitus has challenged health-care professionals. It stands among the leading causes of mortality in the present world. It warrants new and versatile approaches to improve mortality and the associated huge quality-adjusted life years lost to it once diagnose...
Men are underrepresented in HIV testing services throughout sub-Saharan Africa. HIV testing is critical to achieve the UNAIDS 95-95-95 goals, as it is the first entry point to HIV care. In Malawi, an estimated 14% of HIV positive men are undiagnosed, while only 6% of HIV positive women remain undiag...
Zanoni BC, et al. BMJ Glob Health 2016;1:e000004. doi:10.1136/bmjgh-2015-000004
Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution and control activities are presented. Strong evidence in...
Air pollution is a major environmental risk factor and contributor to chronic, noncommunicable diseases (NCDs). However, most public health approaches to NCD prevention focus on behavioural and biomedical risk factors, rather than environmental risk factors such as air pollution. This article discus...
The UK government hosted the Global Vaccine Summit on June 4, 2020 under the patronage of the Rt. Hon. Boris Johnson, Prime Minister of the United Kingdom of Great Britain and Northern Ireland. The meeting was held by videoconference in light of the ongoing COVID-19 pandemic. 2. The Summit brought...
The GAP articulates five objectives for tackling AMR, and sets out the tasks required to achieve them, highlighting
roles and responsibilities for country governments, the One Health Tripartite organizations (FAO, OIE and WHO) and other national and international partners. To ensure that all stakeh...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
